Lerato Mohapi
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, HIV Research and Treatment, Pneumocystis jirovecii pneumonia detection and treatment, Tuberculosis Research and Epidemiology
Most-Cited Works
- → Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis(2011)538 cited
- → One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis(2019)362 cited
- → Maraviroc versus Efavirenz, Both in Combination with Zidovudine‐Lamivudine, for the Treatment of Antiretroviral‐Naive Subjects with CCR5‐Tropic HIV‐1 Infection(2010)265 cited
- → Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort(2009)231 cited
- → Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007(2010)228 cited
- → Body mass index and risk of tuberculosis and death(2010)170 cited
- → Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study(2013)168 cited
- → Antiretroviral Therapies in Women after Single-Dose Nevirapine Exposure(2010)126 cited
- → Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa(2010)115 cited
- → Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study(2015)110 cited